News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
612,589 Results
Type
Article (40250)
Company Profile (178)
Press Release (572143)
Multimedia
Podcasts (120)
Webinars (25)
Section
Business (158670)
Career Advice (1674)
Deals (30088)
Drug Delivery (139)
Drug Development (85578)
Employer Resources (144)
FDA (15463)
Job Trends (12283)
News (293884)
Policy (29503)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2402)
Academic (1)
Accelerated approval (52)
Adcomms (38)
Allergies (180)
Alliances (41673)
ALS (224)
Alzheimer's disease (1891)
Antibody-drug conjugate (ADC) (500)
Approvals (15820)
Artificial intelligence (698)
Autoimmune disease (324)
Automation (48)
Bankruptcy (295)
Best Places to Work (10278)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (135)
Bladder cancer (206)
Brain cancer (78)
Breast cancer (786)
Cancer (6120)
Cardiovascular disease (511)
Career advice (1442)
Career pathing (35)
CAR-T (349)
CDC (47)
Celiac Disease (3)
Cell therapy (929)
Cervical cancer (50)
Clinical research (74964)
Collaboration (2066)
Company closure (7)
Compensation (1149)
Complete response letters (98)
COVID-19 (2724)
CRISPR (100)
C-suite (1107)
Cystic fibrosis (151)
Data (8191)
Decentralized trials (3)
Denatured (29)
Depression (183)
Dermatology (93)
Diabetes (603)
Diagnostics (6636)
Digital health (53)
Diversity (11)
Diversity, equity & inclusion (35)
Drug discovery (321)
Drug pricing (176)
Drug shortages (32)
Duchenne muscular dystrophy (298)
Earnings (66627)
Editorial (63)
Employer branding (18)
Employer resources (123)
Events (93928)
Executive appointments (1024)
FDA (19253)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1717)
Gene editing (231)
Generative AI (61)
Gene therapy (745)
GLP-1 (1138)
Government (4478)
Grass and pollen (7)
Guidances (402)
Healthcare (17299)
HIV (86)
Huntington's disease (61)
IgA nephropathy (104)
Immunology and inflammation (323)
Immuno-oncology (100)
Indications (194)
Infectious disease (3073)
Inflammatory bowel disease (232)
Inflation Reduction Act (15)
Influenza (139)
Intellectual property (289)
Interviews (288)
IPO (15252)
IRA (58)
Job creations (2292)
Job search strategy (1197)
JPM (55)
Kidney cancer (21)
Labor market (85)
Layoffs (536)
Leadership (46)
Legal (6505)
Liver cancer (103)
Longevity (31)
Lung cancer (806)
Lymphoma (440)
Machine learning (58)
Management (48)
Manufacturing (957)
MASH (210)
Medical device (12283)
Medtech (12400)
Mergers & acquisitions (16077)
Metabolic disorders (1597)
mRNA (214)
Multiple sclerosis (198)
NASH (22)
Neurodegenerative disease (460)
Neuropsychiatric disorders (118)
Neuroscience (3505)
Neurotech (1)
NextGen: Class of 2026 (5389)
Non-profit (3776)
Now hiring (58)
Obesity (749)
Opinion (332)
Ovarian cancer (231)
Pain (273)
Pancreatic cancer (323)
Parkinson's disease (386)
Partnered (30)
Patents (588)
Patient recruitment (716)
Peanut (64)
People (49326)
Pharmaceutical (41)
Pharmacy benefit managers (22)
Phase 1 (23552)
Phase 2 (33037)
Phase 3 (24670)
Pipeline (8949)
Policy (310)
Postmarket research (2470)
Preclinical (9178)
Press Release (35)
Prostate cancer (319)
Psychedelics (67)
Radiopharmaceuticals (336)
Rare diseases (1144)
Real estate (4175)
Recruiting (55)
Regulatory (24074)
Reports (49)
Research institute (2357)
Resumes & cover letters (254)
Rett syndrome (40)
RNA editing (23)
RSV (79)
Schizophrenia (189)
Series A (295)
Series B (219)
Service/supplier (8)
Sickle cell disease (109)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (42)
Startups (3005)
State (1)
Stomach cancer (20)
Supply chain (111)
Tariffs (67)
The Weekly (90)
Vaccines (1096)
Venture capital (103)
Weight loss (502)
Women's health (126)
Worklife (19)
Date
Today (159)
Last 7 days (521)
Last 30 days (3311)
Last 365 days (29414)
2026 (12889)
2025 (29264)
2024 (33452)
2023 (38061)
2022 (47961)
2021 (51446)
2020 (49259)
2019 (40897)
2018 (31160)
2017 (29564)
2016 (27600)
2015 (32294)
2014 (24221)
2013 (19013)
2012 (20071)
2011 (20952)
2010 (19274)
Location
Africa (680)
Alabama (89)
Alaska (4)
Arizona (251)
Arkansas (13)
Asia (37272)
Australia (6693)
California (12738)
Canada (3635)
China (1421)
Colorado (540)
Connecticut (547)
Delaware (365)
Europe (84597)
Florida (1918)
Georgia (409)
Hawaii (3)
Idaho (54)
Illinois (914)
India (84)
Indiana (543)
Iowa (20)
Japan (527)
Kansas (123)
Kentucky (46)
Louisiana (41)
Maine (68)
Maryland (1491)
Massachusetts (9028)
Michigan (339)
Minnesota (624)
Mississippi (5)
Missouri (134)
Montana (32)
Nebraska (24)
Nevada (143)
New Hampshire (82)
New Jersey (3271)
New Mexico (26)
New York (3347)
North Carolina (1591)
North Dakota (9)
Northern California (6411)
Ohio (343)
Oklahoma (23)
Oregon (42)
Pennsylvania (2530)
Puerto Rico (26)
Rhode Island (38)
South America (917)
South Carolina (83)
South Dakota (1)
Southern California (5050)
Tennessee (194)
Texas (2123)
United States (44400)
Utah (373)
Vermont (1)
Virginia (309)
Washington D.C. (72)
Washington State (1016)
West Virginia (3)
Wisconsin (126)
Wyoming (2)
612,589 Results for "anaheim clinical trials act".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CDC
NIH’s Jay Bhattacharya Steps In as Acting CDC Chief
Jay Bhattacharya will become the latest leader of the CDC on an acting basis, days after Jim O’Neill stepped aside.
February 18, 2026
·
1 min read
·
Annalee Armstrong
CDC
CDC Left Leaderless Again After Acting Director Departs HHS
Jim O’Neill was deputy secretary at the Department of Health and Human Services and also acting director of the CDC after the abrupt ouster of Susan Monarez in August 2025.
February 16, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026
Over 300 million patients are infected with HCV, HBV, HDV, and their co-infections. MDL-001 is the first oral small molecule to demonstrate potent, direct-acting antiviral activity across all three viruses and their co-infections.
February 18, 2026
·
1 min read
Regulatory
Amgen, AstraZeneca join FDA effort harnessing cloud for real-time clinical trials
The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the cloud—a system that could “compress drug development timelines,” Jefferies analysts said.
April 29, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
December 22, 2025
·
4 min read
IN PARTNERSHIP WITH MEDSIR
Webinar: The Future is Collaborative: Transforming Clinical Trials
This webinar explores how collaborative-initiated trials and Investigator-Initiated Trials (IITs) are complementing traditional drug development to accelerate innovation, advance precision medicine, and address clinically meaningful questions.
March 3, 2026
·
1 min read
·
BioSpace Insights
Press Releases
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
April 15, 2026
·
9 min read
Press Releases
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 18, 2026
·
9 min read
Weight loss
Lilly CEO shades amylin rivals AbbVie, Pfizer in cutthroat battle for obesity’s next act
Amylin drugs have become the next big thing in obesity. Eli Lilly CEO David Ricks, understandably, thinks his rivals don’t have a chance for one key reason.
April 30, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
May 4, 2026
·
5 min read
1 of 61,259
Next
